Preliminary studies reveal conolidine may inhibit certain ion channels, lessening neuronal excitability and restricting suffering signals. This system is particularly relevant in neuropathic suffering, where abnormal signaling leads to persistent discomfort. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral